Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 13.50
-0.35 (-2.53%)
Sep 14, 2026, 4:29 PM CET
Navamedic ASA Market Cap
Navamedic ASA has a market cap or net worth of 323.75 million as of September 14, 2026. Its market cap has decreased by -16.68% in one year.
Market Cap
323.75M
Enterprise Value
453.80M
Revenue
574.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.50
ChartMarket Cap Chart
Since March 31, 2006, Navamedic ASA's market cap has increased from 111.70M to 323.75M, an increase of 189.85%. That is a compound annual growth rate of 5.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 323.75M | -43.28% |
| Dec 30, 2025 | 570.76M | 25.74% |
| Dec 30, 2024 | 453.93M | -28.72% |
| Dec 29, 2023 | 636.85M | 5.92% |
| Dec 30, 2022 | 601.25M | 8.19% |
| Dec 30, 2021 | 555.75M | 90.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.50B |
| Circio Holding ASA | 3.50B |
| Thor Medical ASA | 1.99B |
| Nordhealth AS | 1.97B |
| Lytix Biopharma ASA | 645.96M |
| INIFY Laboratories AB | 623.35M |
| Gentian Diagnostics ASA | 609.07M |
| Zelluna ASA | 602.98M |